The Office of the Vice President for Research and the university's Technology Commercialization office hosted their annual Inventor Recognition Event this past week. This year’s event recognized 455 University inventors whose technologies were licensed or patented between July 2016 and June 2018. Of the 455 recognized, Branden Moriarity, PhD, received the Early Innovator award.

Dr. Moriarity is currently working on harnessing the power of genome engineering in order to develop innovative immunotherapy approaches for treating highly lethal forms of cancer. Moriarity’s work, combined with that of his colleagues, was the foundation for B-MoGen Biotechnologies Inc., a University startup company launched in 2016. He currently serves as the company's chief scientific officer.